Monthly archive | PharmaTutor

19 January 2016

Opportunity for Senior PVP in Quintiles

Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. Our network of 23,000 engaged professionals in 60 countries around the globe works with an unwavering commitment to patients, safety and ethics — ensuring a higher level o f healthcare for people. For our biopharmaceutical customers, we help them navigate risk and seize opportunities in an environment where change is constant.

19 January 2016

Walk in at Mankind for posts of Area Sales Manager, Sales Officer, Territory Supervisor (Sales Rep.)

Mankind Pharma, the 7^th largest Pharmaceutical Company of India, was incepted in 1995 with a meagre capital of 50 lakhs and 20 employees. Today, we are amongst the top 5 fastest growing Pharmaceutical companies of India with an employee base of more than 10000 and heading towards a turnover of INR 3000 crores. We aspire to aid the community in leading a healthy life through two parallel objectives: formulating, developing & commercializing medicines and delivering affordable & accessible medication that satisfies urgent medical needs.

19 January 2016

Recruitment for Assistant Professors in Global College of Pharmacy

Global Group of Institution is a pioneering institute in Engineering & Pharmacy, committed to pursuing excellence with creativity and integrity. The college intends to recruit faculty in Pharmaceutics, Pharmaceutical Chemistry, Pharmacology and Pharmacognosy.

19 January 2016

Career for Talent Acquisition Specialist at ICON Clinical Reaserch

ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support Clinical Development – from compound selection to Phase I - IV clinical studies
ICON enjoys a strong reputation for quality and is focused on staff development. We make it our mission to attract the most diverse and creative minds into the business and we continually strive to provide opportunities for our people to excel, grow and build a great career. We understand that our greatest asset is the skills and talents of our people and they are truly what set us apart.

19 January 2016

National symposium on Molecular modeling and drug discovery research at ADINA Institute of Pharmaceutical Sciences

ADINA Institute of Pharmaceutical Sciences (AIPS) was established in 2005 under aegis of Shri. Prem Chand Jain Memorial Society for Education with an aim of importing quality education. We are providing research oriented education in its fully wi-fi campus, experienced faculty members and other facilities as per the norms and standards of AICTE, PCI and RGPV. AIPS has modern lecture halls, well equipped laboratories, e-liabrary, computer labs with Internet facility. It is an ISO9001:2000 certified institute.

Read more about Novel nanotherapy may beat antibiotic-resistant superbugs

A novel light-activated nanotherapy developed by researchers at the University of Colorado- Boulder may be an effective weapon against the drug-resistant bacteria, say researchers including one of Indian-origin.

Read more about Cranberry can help fight urinary tract infections in babies

Cranberry extracts can help fighting urinary tract infections (UTIs) or bladder infection in breast-fed babies less than one year of age, new research says

Read more about Green vegetable intake can cut glaucoma risk

Greater intake of dietary nitrate and green leafy vegetables is associated with a 20-30 percent lower risk of primary open-angle glaucoma (POAG), according to a study.

Read more about BENEPALI®, the First Etanercept Biosimilar Referencing Enbrel®, Approved in the European Union

The joint venture between Biogen and Samsung BioLogics, Samsung Bioepis, has been granted European Commission (EC) approval for BENEPALI® , an etanercept biosimilar referencing Enbrel®. BENEPALI has been granted marketing authorization in the European Union (EU) for the treatment of adults with moderate to severe rheumatoid arthritis (RA), psoriatic arthritis, non-radiographic axial spondyloarthritis and plaque psoriasis. Biogen intends to make BENEPALI available for patients in the coming weeks.

Read more about FDA Issues Complete Response Letter for KyndrisaTM for Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping

BioMarin Pharmaceutical Inc. announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response letter to the Company's New Drug Application (NDA) for KyndrisaTM (drisapersen) for the treatment of Duchenne muscular dystrophy (Duchenne) amenable to exon 51 skipping.
amenable to exon

Search

January 2016

Opportunity for Senior PVP in Quintiles

RECOMMENDED POSTS

Subscribe with us

Jobs by Category